Health care activity in a headache-specific clinic;Actividad asistencial en una consulta específica de cefalea

Revista de Neurologia

Volumn 39, Issue 5, 2004, Pages 401-405

  Garcia Escriva A ^a   Asensio Asensio, Montserrat ^a   Lopez Hernandez N ^a   Gonzalez Aznar O J ^a   Oliver Navarrete, C ^a   Alvarez Sauco M ^a   Pampliega Perez A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Characteristics; Classification; Epidemiology; Headache; Specific visit; Treatment

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CODEINE; DIPYRONE; ERGOTAMINE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DAILY HEADACHE; FAMILY HISTORY; FEMALE; HEADACHE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PROSPECTIVE STUDY; SIDE EFFECT; SOCIOECONOMICS; SYMPTOMATOLOGY; TENSION HEADACHE;

EID: 8144222076     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3905.2004203     Document Type: Article

References (29)

1. Láinez JM, Vioque J, Hernández-Aguado I, Tifus F. Prevalence of migraine in Spain: an assessment of the questionnaire's validity by clinical interview. In Olesen J, ed. Headache classification and epidemiology. New York: Raven Press; 1994. p. 221-6.
2. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44: 1147-57.
3. Cull RE, Wells NEJ, Miocevich M. The economic cost of migraine. Br Med J 1992; 2: 103-15.
4. Láinez JM. Migraña y calidad de vida. Neurología 1998; 13 (Supl 2): 1-8.
5. Sánchez-Migallón MJ, Galiano M, Fernández Y. La cefalea en la consulta de neurología general. Neurología 2000; 15: 274-7.
6. Gracia-Naya M, Grupo de estudio de Neurólogos Aragoneses. Importancia de las cefaleas en las consultas de Neurología. Rev Neurol 1999; 29: 393-6.
7. Gracia-Naya M. Coste-eficacia del tratamiento con triptanes en España. Rev Neurol 2001; 33: 921-4.
8. Osterhaus JT, Townsend RJ, Gandek B, Ware JE Jr. Measuring the functional status and well-being of patients with migraine headache. Headache 1994; 34: 337-43.
9. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993; 20: 131-7.
10. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labor costs of migraine headache in the US. Pharmacoeconomics 1992; 2: 67-76.
11. Fernández-Concepción O, Canuet-Delis L. Discapacidad y calidad de vida en pacientes con migraña: factures determinantes. Rev Neurol 2003; 36: 1105-12.
12. Láinez JM. Prevalencia de migrana laboral y su repercusión económica. Revista de la Asociación Española de Especialistas en Medicina del Trabajo 1995; Supl 1:3-9.
13. Fishman P, Black L. Indirect costs of migraine in a managed care population. Cephalalgia 1999; 19: 50-7.
14. Headache Clasification Committe of the Internacional Headache Society. Classification and diagnostic criteria for headche disoders, cranial neuralgia and facial pain. Cephalalgia 1988; 8: 1-96.
15. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994; 34: 1-7.
16. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47: 871-5.
17. Leira R, Láinez JM, Pascual J, Díez-Tejedor E, Morales F, Titus F, et al. Estudio español de calidad de vida en migraña (I). Perfil del paciente con migraña que acude a consultas de Neurología. Neurología 1998; 13: 287-91.
18. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: Epidemiology and patterns of health care use. Neurology 2002; 58: 885-94.
19. Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lantéri-Minet M, et al. Prevalence and clinical characteristics of migraine in France. Neurology 2002; 59: 232-7.
20. Gracia-Naya M, Latorre-Jiménez AM. Diferencias entre los pacientes con migraña enviados a una unidad de cefaleas o a una consulta general de Neurología. Rev Neurol 2003; 37: 521-4.
21. Serrano-Dueñas M. Cefalea tipo tensional crónica y depresión. Rev Neurol 2000; 30: 822-6.
22. Merikangas KR, Angst J, Isler R. Migraine and psychopathology: results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990; 47: 849-53.
23. Breslau M, Davis GC, Andresky P. Migraine, psychiatric disoders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23.
24. Gracia-Naya M, Grupo de Estudio de Neurólogos Aragoneses. La cefalea de tensión cronica en las consultas externas de Neurología. Rev Neurol 2000; 31: 929-32.
25. Passchiaer J, Andrasik F. Physiological factors. In Olesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York: Raven Press; 1993. p. 233-40.
26. Peatfield RC, Olesen J. Precipitating factors. In Olesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. N. York: Raven Press; 1993. p. 241-6.
27. Alter M, Daule JR, Franlin G, Frishberg BM, Goldstein ML, Greenberg MK, et al. Report of the Quality Standars Subcommittee of the American Academy of Neurology. Practice parameter: the utility of neuroimaging in the evaluation of patients with normal neurological examination. Neurology 1994; 44: 1353-4.
28. Frishberg BM. The utility of neuroimaging in the evaluation of headache in patients with normal neurological examination. Neurology 1994; 44: 1191-7.
29. Grupo de Estudio de Cefalea de la Sociedad Española de Neurología. Actitud diagnóstica y terapéutica en la cefalea. Recomendaciones 1997. Madrid: Ergón; 1996.